Prolgolimab for advanced facial melanoma (a clinical case description and a brief literature review)

Melanoma of the skin can certainly be attributed to the group of aggressive malignant neoplasms, which are characterized by high mortality and frequent relapses. However, in recent years, there have been revolutionary changes in the treatment of melanoma. The introduction of targeted and immunotherapy into clinical practice has significantly changed the unfavorable prognosis and thus increased the life expectancy of patients. This article presents a clinical case of the successful use of the domestic immuno-oncological drug prolgolimab in a patient with advanced facial melanoma of the older age group. Also, a brief description of key clinical studies devoted to the study of domestic monoclonal antibodies in skin melanoma is given.

Authors

Institutions

Publication Details

Journal
Head and neck tumors (HNT)
Published
2026-11-20
DOI
https://doi.org/10.17650/2222-1468-2026-16-3-105-109
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prolgolimab for advanced facial melanoma (a clinical case description and a brief literature review)

Evgenia Kuzmina, S.A. Golubeva, P. V. Golubev, Vladislav Kuzmin et al.
Head and neck tumors (HNT)
Cutaneous Melanoma Detection and Management
article

Prolgolimab for advanced facial melanoma (a clinical case description and a brief literature review)

Evgenia Kuzmina, S.A. Golubeva, P. V. Golubev, Vladislav Kuzmin, L. I. Barskaya
article en

Abstract

Melanoma of the skin can certainly be attributed to the group of aggressive malignant neoplasms, which are characterized by high mortality and frequent relapses. However, in recent years, there have been revolutionary changes in the treatment of melanoma. The introduction of targeted and immunotherapy into clinical practice has significantly changed the unfavorable prognosis and thus increased the life expectancy of patients. This article presents a clinical case of the successful use of the domestic immuno-oncological drug prolgolimab in a patient with advanced facial melanoma of the older age group. Also, a brief description of key clinical studies devoted to the study of domestic monoclonal antibodies in skin melanoma is given.

Head and neck tumors (HNT)Vol. 16(3)
Sechenov University (RU), Ministry of Health of the Russian Federation (RU), Medical Radiological Research Center (RU), City Clinical Hospital (RU), P.A. Hertzen Moscow Oncology Research Institute (RU)
Cutaneous Melanoma Detection and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon